At GSK, we work closely with a range of patient organisations in different disease areas such as asthma, rare diseases and HIV.
We share these organisations’ visions for a healthcare system that provides the best standard of care for preventing, treating and managing disease. This includes ensuring people living with an illness or disease have timely access to the most effective treatments, services and information available.
In New Zealand, we support groups such as Body Positive NZ, Asthma New Zealand and Positive Women.
In order to help support the important work these patient groups do, we provide funding to help with defined events, projects or activities. However, we acknowledge patient organisations must remain independent and for this reason we limit our financial support to no more than 25% of a group’s total annual revenue.
As part of our commitment to transparency, we also publicly disclose which groups we have supported each year.
Patient group funding
To ensure patient groups retain their independence, we work to strict policies and engagement guidelines that prevent us from proactively approaching organisations.
Patient advocacy groups who are interested in receiving project funding or support for a defined project, event, or activity should submit a one-page letter outlining the project details and value of the grant request to: MEL_Corporate_Affairs@gsk.com